lp-a.org

Epidemiology

Cumulative Lp(a) burden, not just a single measurement, tracks with worse outcomes in 2,634 heart attack patients (Lipids Health Dis 2025)

Original title: Association between lipoprotein(a) levels, cumulative lipoprotein(a) burden, and cardiovascular outcomes in patients with acute myocardial infarction: a large-scale cohort study

Lipids Health Dis · · 7

Wang Z, Zhang J, Tang J

This cohort study followed 2,634 patients hospitalised with acute myocardial infarction who underwent coronary angiography at Zhongda Hospital, Southeast University, between 2013 and 2021, testing both single-measurement Lp(a) and cumulative Lp(a) burden (CumLp(a)) against major adverse cardiac and cerebrovascular events (MACCE). Over a median 55.2-month follow-up, MACCE occurred in 907 patients (34.40%). Both higher Lp(a) and higher CumLp(a) independently predicted MACCE (HR 1.652 and 1.697), cardiovascular death (HR 2.157 and 1.675), non-fatal MI (HR 3.455 and 3.759), and non-fatal stroke (HR 1.930 and 2.032), with each one-unit rise in CumLp(a) raising MACCE risk by 1.3%. Restricted cubic spline modelling showed non-linear, threshold effects for both measures. This large single-centre cohort suggests that tracking Lp(a) burden over time, not just a one-off value, may refine prognosis after myocardial infarction.

Read the paper (DOI)PubMed

Original abstract

AIMS: To determine whether lipoprotein(a) [Lp(a)] and cumulative Lp(a) (CumLp(a)) are associated with adverse outcomes in patients with acute myocardial infarction (AMI). METHODS: This cohort study included 2,634 hospitalized patients diagnosed with AMI who underwent coronary angiography at Zhongda Hospital, Southeast University, from July 2013, to December 2021. The main outcome was major adverse cardiac and cerebrovascular events (MACCE), defined as cardiovascular (CV) death, non-fatal myocardial infarction, non-fatal stroke, or unplanned revascularization:occurring singly or in combination. We used Cox proportional hazards models, with subgroup and sensitivity analyses, restricted cubic spline (RCS) modeling, and threshold-effect assessment to evaluate the relationships between Lp(a), CumLp(a), and prognosis. RESULTS: Across a median 55.2-month follow-up, 907 participants (34.40%) experienced a MACCE, 342 (13.00%) patients had CV death, 177 (6.70%) patients had non-fatal MI, 202 (7.70%) patients had non-fatal stroke, 399 (15.10%) patients underwent unplanned revascularization, and all-cause death occurred in 547 (20.80%) patients. Multivariable Cox regression models demonstrated a significantly increased risk of MACCE, CV death, non-fatal MI, and non-fatal stroke in both the higher Lp(a) and higher CumLp(a) groups compared with the lower groups (HRs for Lp(a): 1.652, 2.157, 3.455, and 1.930; HRs for CumLp(a): 1.697, 1.675, 3.759, and 2.032), and every one-unit rise in CumLp(a), the risk of MACCE, CV death, non-fatal MI and non-fatal stroke increased by 1.3%, 1.4%, 1.9% and 1.2%, respectively. The majority of subgroup and sensitivity checks consistently supported a stable link between Lp(a)/CumLp(a) and the risks of MACCE, CV death, non-fatal MI, and stroke. Analyses using RCS and threshold models revealed that Log10(Lp(a)) had both nonlinear and threshold effects on the risks of MACCE and each single event other than unplanned revascularization, while log10-transformed CumLp(a) showed nonlinear and threshold associations only with MACCE, CV death, and non-fatal MI (nonlinearity P < 0.05). CONCLUSIONS: Higher levels of Lp(a) and CumLp(a) are linked to a greater risk of poor outcomes among patients with AMI as the index event, highlighting their potential value for risk stratification and guiding clinical decision-making.

epidemiology

Summary written by lp-a.org from the published abstract; figures as published. Page updated 17 August 2026. Methods.